is semaglutide on shortage list the As of February 21, 2025, the FDA updated its drug US judge upholds FDA's removal

GLP-1 is produced in the gut after we eat a meal and helps to lower blood sugar levels by stimulating the production of insulin and suppressing the release of the hormone glucagon

Here's how to find the best of the medications to reduce alcohol cravings for you, whether that's naltrexone, acamprosate, or another pick.

Are you tired of endless dieting and exercise routines that seem to lead nowhere

CagriSema is a fixed-dose combination of cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist), and is currently an experimental obesity drug developed by Novo Nordisk

Craving Control: Formulated to naturally support the feeling of fullness and help you manage unnecessary snacking